Penn Center for Myeloproliferative Neoplasms

Saar I Gill

faculty photo

Saar I Gill

Associate Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Room 8-101
Smilow Translational Research Center
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: (215) 573-4015
Lab: (215) 573-4015
Education:
MBBS (medicine)
University of Melbourne, 1999.
PhD (immunology)
University of Melbourne, 2011.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Blood and Marrow Transplantation
Leukemia
Myelodysplastic Syndromes
Myeloproliferative Neoplasms
Lymphoproliferative Neoplasms
Bone Marrow Failure

Description of Research Expertise

Tumor Immunology
Chimeric Antigen Receptor T cells
Mouse Models of Human Leukemia
Murine Xenografts
Adoptive Cellular Therapy
Genetic Engineering of T cells
Flow Cytometry

Selected Publications

Janaki Manoja Vinnakota, Francesca Biavasco, Marius Schwabenland, Chintan Chhatbar, Rachael C Adams, Daniel Erny, Sandra Duquesne, Nadia El Khawanky, Henrike Salié, Dimitrios Athanassopoulos, Lukas Braun, Dominik Schmidt, Viktor Fetsch, Rebeka N. Javorniczky, Jenny N.H.G Ho, Reinhard Marks, Ralph Wäsch, Federico Simonetta, Geoffroy Andrieux, Dietmar Pfeifer, Gianni Monaco, Christian Capitini, Terry J. Fry, Thomas Blank, Bruce R Blazar, Eva-Maria Wagner Drouet, Matthias Theobald, Clemens Sommer, Matthias Stelljes, Christian Reicherts, Astrid Jeibmann, Jens Schittenhelm, Camelia-Maria Monoranu, Andreas Rosenwald, K. Martin Kortüm, Leo Rasche, Hermann Einsele, Philipp Tobias Meyer, Joachim Brumberg, Andreas Mackensen, Michael von Bergwelt-Baildon, Roland Coras, Nathalie L. Albert, Laura M. Bartos, Matthias Brendel, Adrien Holzgreve, Melanie Boerries, Crystal L. Mackall, Justus Duyster, Natalie Koehler, Felix Strübing, Bertram Bengsch, Marco Ruella, Marion Subklewe, Louisa von Baumgarten, Saar Gill, Marco Prinz, Robert Zeiser: Immune-Effector-Cell-Associated-Neurotoxicity-Syndrome (ICANS) Pathophysiology Is Mediated By Microglia TGF-β-Activated Kinase-1 Signaling. American Society of Hematology, annual meeting, San Diego, CA Dec 2023 Notes: "Poster Presentation"

Katherine Cummins & Saar Gill: Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia. Hematol Oncol Clin North Am. 37(6): 1125-1147, Dec 2023.

Ashley D Hadjis, MD*, Griffin W White*, Christopher Catania*, Noelle V. Frey, MD, MS, Saar Gill, MD, PhD, Elizabeth O Hexner, MD, MSTR, Ximena Jordan Bruno, MD, Catherine Lai, MD, Andrew H Matthews, MD*, Mary Ellen Martin, MD, Daria V Babushok, MD, PhD, Alexander Perl, David L. Porter, MD, Alison W Loren, MD, Keith W Pratz, MD, Selina M Luger, MD, FRCPC and Shannon R McCurdy, MD: Frail and Pre-Frail Older Adults with Acute Myeloid Leukemia Have Inferior Survival Due to Higher Rates of Disease-Related American Society of Hematology annual meeting, San Diego, CA. Dec 2023 Notes: "Poster Presentation"

Margaret Rowe, MD1*, Daria V Babushok, MD, PhD2, Martin Carroll, MD3, Alison Carulli, PharmD1*, Noelle V. Frey, MD, MS4, Saar Gill, MD, PhD4, Elizabeth O Hexner, MD, MSTR4, Rebecca Hirsh, MD1*, Nasheed Hossain, MD5*, Catherine Lai, MD4, Alison W Loren, MD4, Selina M Luger, MD, FRCPC6, Ivan Maillard4, Shannon R McCurdy, MD4, Andrew H Matthews, MD4*, Mary Ellen Martin, MD4, Vikram R Paralkar, MD4, Alexander Perl4, David L. Porter, MD7, Keith W Pratz, MD4,5, Edward A. Stadtmauer, MD8 and Ximena Jordan Bruno, MD4: Comparing Cairo Bishop and Howard Criteria for Identifying Clinically Meaningful Tumor Lysis Syndrome Among Acute Myeloid Leukemia Patients Treated with Venetoclax and Hypomethylating Agents: A Single Center Experience. American Society of Hematology annual meeting, San Diego, CA. Dec 2023 Notes: "Poster Presentation"

Xiaoli Mi, MD, Dennis Yuan,PhD, Rebecca Murray, BS, Jani Huuhtanen, M.D., Beatrice Zhang, Jean Quentin, Olga Shestova, PhD, David L. Porter, MD Satu Mustjoki, MD, Saar Gill, MD, Dan A. Landau, MD.: Molecular Attributes of CAR T Cell Fitness in Patients with Chronic Lymphocytic Leukemia. American Society of Hematology annual meeting, San Diego, CA. Dec 2023 Notes: "Poster Presentation"

Matthew P Connor, MD, Neeharika Prathapa, MBBS, Noelle V. Frey, MD, MS, Saar Gill, MD, PhD, Elizabeth O Hexner, MD, MSTR, Ximena Jordan Bruno, MD, Catherine Lai, MD, Alison W Loren, MD, Selina M Luger, MD, FRCPC, Andrew H Matthews, MD, Shannon R McCurdy, MD, Alexander Perl, David L. Porter, MD, Arlene Zeringue, Joseph H. Oved, MD, Timothy S Olson, MD, PhD, Keith W Pratz, MD, Daria V Babushok, MD, PhD.: Hypomethylating Agents Are Associated with High Rates of Hematologic Toxicity in Patients with Secondary MDS/AML That Develops after Acquired Aplastic Anemia. American Society of Hematology, annual meeting, San Diego, CA. Dec 2023 Notes: "Poster Presentation"

Anand S Bhagwat, Leonel Torres, Olga Shestova, Maksim Shestov, Noelle V. Frey, Elizabeth O Hexner, Selina M Luger, Alison W Loren, Mary Ellen Martin, Shannon R McCurdy, Alexander Perl, Edward A. Stadtmauer, James K. Mangan, Jennifer Brogdon, Joseph A Fraietta, Wei-Ting Hwang, Don L. Siegel, Saad S. Kenderian, David L. Porter, Carl June, Saar Gill.: Cytokine Release Syndrome Results in Reduced AML Killing By CD123 CAR T Cells. American Society of Hematology annual meeting, San Diego, CA. Dec 2023 Notes: "Poster Presentation"

Patrick Mellors, MD, Ana Nottingham, Maksim Shestov, Maria Basil, MD, Saar Gill, MD.: Single Cell Transcriptomics of Bronchiolitis Obliterans Syndrome. American Society of Hematology annual meeting, San Diego, CA. Dec 2023 Notes: "Poster Presentation"

Xin Wang, MD1, Phyllis Gimotty, PhD2*, Andrew H Matthews, MD1*, Ronac Mamtani, MD, MSCE1*, Selina M Luger, MD, FRCPC1, Elizabeth O Hexner, MD, MSTR1, Daria V Babushok, MD, PhD1, Shannon R McCurdy, MD1, Noelle V. Frey, MD, MS1, Ximena Jordan Bruno, MD1, David L. Porter, MD1, Saar Gill, MD, PhD1, Mary Ellen Martin, MD1, Vikram R Paralkar, MD1, Ivan Maillard1, Alison W Loren, MD1, Alexander Perl1, Keith W Pratz, MD1, Kelly D. Getz, PhD, MPH2,3* and Catherine Lai, MD1: Evolving Racial/Ethnic Disparities in AML Survival in the Novel Therapy Era: Real-World Evidence of Improved Survival in Older Patients with the Largest Improvement in Non-Hispanic Black Patients. American Society of Hematology annual meeting, San Diego, CA. Dec 2023 Notes: "Poster Presentation"

Christopher Snyder & Saar Gill: Good CARMA: Turning bad tumor-resident myeloid cells good with chimeric antigen receptor macrophages. Immunol Rev. 320(1): 236-249, Nov 2023.

back to top
Last updated: 01/10/2024
The Trustees of the University of Pennsylvania
 

The Penn Difference

  • Individualized Treatment Plan
  • Expert Treatment Team Knowledgeable in Myeloproliferative Disorders
  • State-of-the-Art Personalized Diagnostic Testing
  • Access to Newest Therapies Through Clinical Trials
  • Comprehensive Bone Marrow Transplantation Service
  • Integrated Care by a Multidisciplinary Treatment Team

Make an Appointment

New Patients:
Abramson Cancer Center
Perelman Center for Advanced Medicine
2nd Floor, West Pavilion
Philadelphia, PA 19104
Phone: 215-615-5858 option 2
Fax: 215-615-5889

Current Patients:
Contact your doctor directly

For General Inquiries:
Call the Myeloproliferative Neoplasms Program at  215-614-1847


Donate


Search